Has Susan Williams received payments from drug or device companies?

Yes. Drug and device makers reported $7,769 in general payments to Susan Williams across 402 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Susan Williams did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Susan Williams come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Susan Williams

Family · Lima, OHNPI 1982794806

Payments from drug & device makers

$7,769in general payments, 2019–2025

Across 402 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Johnson & Johnson$942
Regeneron Healthcare Solutions, Inc.$830
Sanofi$599
Novartis$546
E.r. Squibb & Sons, L.L.C.$523
plus $3K from 23 others

What the payments were for

Food & beverage$6,94789%
Education$82211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	115	$1,538
Johnson & Johnson	32	$942
Regeneron Healthcare Solutions, Inc.	38	$830
Sanofi	24	$599
Novartis	32	$546
E.r. Squibb & Sons, L.L.C.	27	$523
Sun Pharmaceutical Industries Inc.	15	$395
Lilly USA, LLC	18	$365
Incyte Corporation	18	$355
Pfizer	17	$314
LEO Pharma Inc.	10	$209
Amgen	10	$209
UCB, Inc.	9	$179
Boehringer Ingelheim	4	$97
Dermavant Sciences, Inc.	5	$90
Sanofi-aventis U.S. LLC	2	$86
Genentech USA, Inc.	4	$77
Galderma Laboratories, L.p.	4	$73
Arcutis Biotherapeutics, Inc.	4	$71
VYNE Pharmaceuticals Inc.	3	$62
Helsinn Therapeutics (U.S.), Inc.	2	$42
Almirall LLC	2	$35
Organon	1	$22
Verrica Pharmaceuticals Inc.	1	$21
Journey Medical Corporation	1	$20
Nabriva Therapeutics, PLC	1	$18
Fresenius Kabi USA, LLC	1	$18
Nobelpharma America, LLC	1	$18
Biofrontera Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EBGLYSS$103
Sotyktu$103
Skyrizi$100

How this compares

$7,769 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	40	$502,411
Skyrizi PenRisankizumab-Rzaa	13	$267,775
Dupixent PenDupilumab	65	$242,673
Cosentyx Unoready PenSecukinumab	11	$145,586
Dupixent SyringeDupilumab	20	$78,327
OtezlaApremilast	12	$56,942
Fluorouracil	58	$3,847
Betamethasone Dipropionate	90	$2,794
Fluocinonide	71	$2,617
Triamcinolone Acetonide	361	$1,866
Ketoconazole	114	$1,726
Metronidazole	27	$1,612
Hydroxyzine Hcl	115	$1,520
Doxycycline Hyclate	65	$1,277
Hydroxychloroquine Sulfate	20	$991

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AmgenOtezla	$209	$56,94212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.

Other family in Lima

Eileen FauldsLewis Center$991K
Leigh Ann PanschDayton$670K
Natalie BelliniMayfield Heights$582K
Kaitlyn LovettMontgomery$286K
Amy RossDayton$281K
Renee OttSandusky$179K
Megan MillerSpringfield$156K
George KnightCincinnati$130K
Jillian HuntCincinnati$116K
Florence StewartNew Albany$113K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →